European Journal of Clinical Investigation

Papers
(The H4-Index of European Journal of Clinical Investigation is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
136
Hydrogen sulphide: Diabetic cardiomyopathy as the paradigm of its pleiotropic function86
Issue Information65
rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings60
Issue Information52
Human blood metabolites and risk of severe COVID‐19: A Mendelian randomization study51
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial50
Progress and challenges in the symbiosis of AI with science and medicine47
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV‐2 variants46
Correction to ‘Association Between Exposure to Air Pollution and Blood Lipids in the General Population of Spain’42
Combination therapy with an SGLT‐2 inhibitor and finerenone in DKD: Are we there yet?40
Clinical implications of vascular dysfunction in acute and convalescent COVID‐19: A systematic review39
Effects of pharmacological inhibition of hyaluronic acid synthesis on experimental endometriosis38
Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease38
Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease37
Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus36
Effects of glucagon‐like PEPTIDE‐1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META‐analysis35
ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function35
Practical considerations for the use of vericiguat in older patients with heart failure and reduced ejection fraction33
Issue Information32
Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study32
Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?32
Adipocyte maturation impacts daunorubicin disposition and metabolism31
Role of PERK‐mediated pathway in the effect of mild hypothermia after cerebral ischaemia/reperfusion31
Impact of Anaemia on Management and Outcomes in Patients With Atrial Fibrillation: Insights From European and Asian Cohorts31
Blood pressure measurement for prediction of chronic pressure overload and cardiovascular events30
Social determinants of health and cardiovascular outcomes in patients with heart failure30
The hinge‐1 domain of Flna is not necessary for diverse physiological functions in mice29
Automatic reorientation algorithm for myocardial perfusion SPECT using segmentation29
Angiopoietin‐like protein 2 and mortality in patients with heart failure—Results from an observational study29
Comparison between thoracic ultrasound and chest x‐ray in detection of non‐infective early complications of cardiac implantable electronic devices implantation ( CRUSADERS29
0.15148901939392